首页> 美国卫生研究院文献>BMJ Case Reports >Case Report: Primary malignant melanoma of uterine cervix with probable origin from benign cervical melanosis
【2h】

Case Report: Primary malignant melanoma of uterine cervix with probable origin from benign cervical melanosis

机译:病例报告:原发性子宫颈恶性黑色素瘤可能起源于良性宫颈黑素病

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

We report a case of primary malignant melanoma of cervix which is a rare malignancy with only around 60 cases being reported. This patient presented with bleeding per vaginum. A large exophytic growth from cervix with black discolouration was seen. International Federation of Gynaecology and Obsterics (FIGO) staging was stage IIa. Histoimmunocytology confirmed the diagnosis of malignant melanoma of cervix. S-100 and HMB-45 are reliable markers for cervical melanomas. We attempted Wertheim's hysterectomy; but, due to extensive disease, paravescical and pararectal fossae could not be dissected and we had to perform type I hysterectomy. The patient was started on adjuvant chemotherapy with dacarbazine. Despite counselling, she refused a complete course of chemotherapy and died after 6 months. Radical surgery, chemotherapy and immunotherapy are the therapeutic modalities used. In bulky disease, neoadjuvant chemotherapy should be considered to reduce the tumour bulk and facilitate required surgery. Prognosis is poor and unpredictable.
机译:我们报告一例原发性宫颈恶性黑色素瘤,这是一种罕见的恶性肿瘤,仅报道了约60例。该患者出现每个阴道出血。可见子宫颈有大量外生生长,并有黑色变色。国际妇产科联合会(FIGO)分期为IIa期。组织免疫细胞学证实了子宫颈恶性黑色素瘤的诊断。 S-100和HMB-45是宫颈黑色素瘤的可靠标志物。我们尝试了Wertheim子宫切除术;但是,由于疾病广泛,因此无法解剖膀胱旁和直肠旁的窝,我们不得不进行I型子宫切除术。该患者开始接受达卡巴嗪辅助化疗。尽管进行了咨询,但她拒绝接受完整的化疗,并在6个月后死亡。根治性手术,化学疗法和免疫疗法是所使用的治疗方式。在大块疾病中,应考虑使用新辅助化疗以减少肿瘤体积并促进所需的手术。预后差且不可预测。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号